EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more

Ibrahim Tohidi-Esfahani, Judith Trotman iD

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Ibrahim Tohidi-Esfahani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ibrutinib changed the landscape of treatment in Waldenström macroglobulinaemia (WM) with excellent responses; however, there are high rates of dose reduction due to adverse events. The impact of this reduced dosing is unclear with regards to outcomes. Sarosiek and colleagues provide valuable data in a very large retrospective study demonstrating that dose reduction is effective in managing adverse events in the majority, with equivalent, if not better, outcomes than those without dose reductions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaProtein Kinase InhibitorsHumansPyrazolesPyrimidinesRetrospective StudiesAdeninePiperidines

Stichwörter der Autor:innen

Waldenstrom macroglobulinaemiabruton tyrosine kinase inhibitoribrutinib

Substanzen

PyrazolesPyrimidinesProtein Kinase InhibitorsibrutinibAdeninePiperidines

Autor:innen und Institutionen

  • Haematology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Judith Trotman

Zitieren

APA

Tohidi-Esfahani, I., & Trotman, J. (2023). Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more. British Journal of Haematology. https://doi.org/10.1111/bjh.18664

Vancouver

Tohidi-Esfahani I, Trotman J. Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more. British Journal of Haematology. 2023. doi:10.1111/bjh.18664

BibTeX
@article{TohidiEsfahani2023,
  author = {Tohidi-Esfahani, Ibrahim and Trotman, Judith},
  title = {Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18664}
}
Kostenlos starten →